These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26500079)

  • 21. Proposed morphologic classification of prostate cancer with neuroendocrine differentiation.
    Epstein JI; Amin MB; Beltran H; Lotan TL; Mosquera JM; Reuter VE; Robinson BD; Troncoso P; Rubin MA
    Am J Surg Pathol; 2014 Jun; 38(6):756-67. PubMed ID: 24705311
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Thoracic neuroendocrine tumors].
    Brambilla E; Lantuejoul S
    Ann Pathol; 2005 Dec; 25(6):529-44. PubMed ID: 16735977
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An overview of practical issues in the diagnosis of gastroenteropancreatic neuroendocrine pathology.
    Chetty R
    Arch Pathol Lab Med; 2008 Aug; 132(8):1285-9. PubMed ID: 18684027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An Update of Neuroendocrine Tumors of the Female Reproductive System.
    Kefeli M; Usubütün A
    Turk Patoloji Derg; 2015; 31 Suppl 1():128-44. PubMed ID: 26177323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of neuroendocrine differentiation in non-small cell lung cancer. The LCSG experience.
    Linnoila RI; Piantadosi S; Ruckdeschel JC
    Chest; 1994 Dec; 106(6 Suppl):367S-371S. PubMed ID: 7988266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical, pathologic and molecular characteristics of pulmonary high-grade neuroendocrine tumors].
    Danel C
    Ann Pathol; 2011 Nov; 31(5 Suppl):S76-8. PubMed ID: 22054468
    [No Abstract]   [Full Text] [Related]  

  • 27. The neuroendocrine system and its tumors: an overview.
    DeLellis RA
    Am J Clin Pathol; 2001 Jun; 115 Suppl():S5-16. PubMed ID: 11993690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung tumours with neuroendocrine differentiation.
    Travis WD
    Eur J Cancer; 2009 Sep; 45 Suppl 1():251-66. PubMed ID: 19775623
    [No Abstract]   [Full Text] [Related]  

  • 29. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
    Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
    Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pulmonary neuroendocrine tumors: study of 90 cases focusing on clinicopathological characteristics, immunophenotype, preoperative biopsy, and frozen section diagnoses.
    Yeh YC; Chou TY
    J Surg Oncol; 2014 Mar; 109(3):280-6. PubMed ID: 24301337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Classification of broncho-pulmonary cancers (WHO 1999)].
    Brambilla E
    Rev Mal Respir; 2002 Sep; 19(4):455-66. PubMed ID: 12417862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroendocrine tumors of the prostate.
    Fine SW
    Mod Pathol; 2018 Jan; 31(S1):S122-132. PubMed ID: 29297494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The spectrum of changes in adults with multifocal pulmonary neuroendocrine proliferations: what is the minimum set of pathologic criteria to diagnose DIPNECH?
    Marchevsky AM; Wirtschafter E; Walts AE
    Hum Pathol; 2015 Feb; 46(2):176-81. PubMed ID: 25532694
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Neuroendocrine tumors of the lung].
    Müller KM
    Pathologe; 2003 Jul; 24(4):297-302. PubMed ID: 14513277
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Pulmonary neuroendocrine tumors : Current review].
    Meyer HJ; Frille A; Tiepolt S; Denecke T
    Radiologie (Heidelb); 2024 Jul; 64(7):546-552. PubMed ID: 38806730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical implications of lung neuroendocrine neoplasm classification.
    Metovic J; Barella M; Harari S; Pattini L; Albini A; Sonzogni A; Veronesi G; Papotti M; Pelosi G
    Expert Rev Anticancer Ther; 2021 Apr; 21(4):377-387. PubMed ID: 33306420
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Utility of the quantitative Ki-67 proliferation index and CD56 together in the cytologic diagnosis of small cell lung carcinoma and other lung neuroendocrine tumors.
    Zheng G; Ettinger DS; Maleki Z
    Acta Cytol; 2013; 57(3):281-90. PubMed ID: 23635388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The new classification of neuroendocrine tumors from the clinical viewpoint].
    Schürmann G; Senninger H
    Z Gastroenterol; 1996 Jun; 34(6):402-3. PubMed ID: 8767831
    [No Abstract]   [Full Text] [Related]  

  • 39. Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
    Brambilla E; Negoescu A; Gazzeri S; Lantuejoul S; Moro D; Brambilla C; Coll JL
    Am J Pathol; 1996 Dec; 149(6):1941-52. PubMed ID: 8952529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of so-called neuroendocrine lung tumors.
    Yesner R
    Exp Mol Pathol; 2001 Jun; 70(3):179-82. PubMed ID: 11417996
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.